Dr Reddys Laboratories (RDY) EBT (2009 - 2026)
Dr Reddys Laboratories (RDY) recorded EBT of $128.44 million in fiscal Q2 2027 (quarter ended Sep 30, 2026), down 38.9% from $210.38 million a year earlier but up 120.1% from the prior quarter.
Dr Reddys Laboratories (RDY) EBT (2009 - 2026) Analysis & Trends
On a TTM basis, Dr Reddys Laboratories' EBT came in at $381.85 million as of Sep 30, 2026, down 56.9% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $584 million, down 35.1% from FY2025.
- Annual EBT has a five-year compound annual growth rate of 10.1% (FY2021 to FY2026).
- Across earlier fiscal years, EBT came in at $900 million in FY2025 (+4.4%), $862 million in FY2024 (+17.4%), $734 million in FY2023 (+72.3%) and $426 million in FY2022 (+18.0%).
- Quarterly EBT has ranged from $21.78 million in fiscal Q4 2026 to $231.58 million in fiscal Q4 2025 over the past five years.
- On a year-over-year basis, EBT has declined for six consecutive quarters, with an average decline of 26.7% over the last eight quarters.
- Peak year-over-year performance for EBT in the last five years was growth of 572.3% in fiscal Q4 2023, against a decline of 90.6% in fiscal Q4 2026 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $58.37 million (Q1 2027), $21.78 million (Q4 2026) and $173.26 million (Q3 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 8.41 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 34.00 Mn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 4.83 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 5.56 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 3.96 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 4.69 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 3.06 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 3.39 Bn |
| 10 | Dr Reddys Laboratories | 12.40 Bn | 11.74 Bn | 472.93 Mn | 128.44 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 128.44 Mn |
| Jun 30, 2026 | 58.37 Mn |
| Mar 31, 2026 | 21.78 Mn |
| Dec 31, 2025 | 173.26 Mn |
| Sep 30, 2025 | 210.38 Mn |
| Jun 30, 2025 | 222.56 Mn |
| Mar 31, 2025 | 231.58 Mn |
| Dec 31, 2024 | 221.97 Mn |
| Sep 30, 2024 | 228.84 Mn |
| Jun 30, 2024 | 225.62 Mn |
| Mar 31, 2024 | 192.86 Mn |
| Dec 31, 2023 | 219.26 Mn |
| Sep 30, 2023 | 231.46 Mn |
| Jun 30, 2023 | 230.00 Mn |
| Mar 31, 2023 | 222.00 Mn |
| Dec 31, 2022 | 162.00 Mn |
| Sep 30, 2022 | 199.00 Mn |
| Jun 30, 2022 | 195.00 Mn |
| Mar 31, 2022 | 33.02 Mn |
| Dec 31, 2021 | 81.00 Mn |
Dr Reddys Laboratories EBT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt&ticker=RDY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebt&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();